CORC

浏览/检索结果: 共6条,第1-6条 帮助

已选(0)清除 条数/页:   排序方式:
High-Dose RAI Therapy Justified by Pathological N1a Disease Revealed by Prophylactic Central Neck Dissection for cN0 Papillary Thyroid Cancer Patients: Is it Superior to Low-Dose RAI Therapy? 期刊论文
WORLD JOURNAL OF SURGERY, 2019, 卷号: 43, 期号: 5
作者:  Wei, Lan;  Bai, Lin;  Zhao, Lina;  Yu, Tianyu;  Ma, Qingjie
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY 期刊论文
2019
作者:  Liu Yan-Qing;  Li Hui;  Liu Jie-Rui;  Lin Yan-Song
收藏  |  浏览/下载:9/0  |  提交时间:2020/01/03
Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer 期刊论文
2019, 卷号: 15, 期号: 21, 页码: 2489-2501
作者:  Iwata Hiroji;  Masuda Norikazu;  Kim Sung-Bae;  Inoue Kenichi;  Rai Yoshiaki
收藏  |  浏览/下载:7/0  |  提交时间:2020/01/03
The role of radioactive iodine therapy in papillary thyroid cancer: an observational study based on SEER 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11
作者:  Tang, Jianing;  Kong, Deguang;  Cui, Qiuxia;  Wang, Kun;  Zhang, Dan
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/05
Knockdown of RAI14 suppresses the progression of gastric cancer 期刊论文
ONCOTARGETS AND THERAPY, 2018, 卷号: 11, 页码: 6693-6703
作者:  Chen, Cheng;  Maimaiti, Aihemaiti;  Zhang, Xin;  Qu, Hui;  Sun, Qilong
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/11
Super enhancer associated RAI14 is a new potential biomarker in lung adenocarcinoma 期刊论文
ONCOTARGET, 2017, 卷号: 8, 期号: 62
作者:  Yuan, Chongze;  Hu, Hong;  Kuang, Muyu;  Chen, Zongwei;  Tao, Xiaoting
收藏  |  浏览/下载:12/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace